drugset / Trial / NCT00464607
Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA
RandomizedParallel-groupOpen-labelTreatment
Summary
Purpose of the study is the evaluation of the tolerability (both local and systemic) and the clinical efficacy (in terms oocytes recovered) of subcutaneously versus intramuscularly administered Merional® (IBSA, Lugano - CH) in patients undergoing controlled ovarian hyperstimulation (COH) in an ART programme (IVF).
Timeline
- Start
- 2001-12
- Primary completion
- —
- Completion
- 2005-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hMG-IBSA | Unknown | — | Subcutaneous |